These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 7953258)

  • 1. Artificial simulation of the early stages of renal stone formation.
    Grases F; Costa-Bauzá A; March JG
    Br J Urol; 1994 Sep; 74(3):298-301. PubMed ID: 7953258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development.
    Costa-Bauzá A; Isern B; Perelló J; Sanchis P; Grases F
    Scand J Urol Nephrol; 2005; 39(3):194-9. PubMed ID: 16118089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factors affecting calcium oxalate dihydrate fragmented calculi regrowth.
    Costa-Bauzá A; Perelló J; Isern B; Sanchis P; Grases F
    BMC Urol; 2006 Jul; 6():16. PubMed ID: 16822299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on calcium oxalate monohydrate crystallization: influence of inhibitors.
    Grases F; Kroupa M; Costa-Bauzá A
    Urol Res; 1994; 22(1):39-43. PubMed ID: 7521089
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Study of the effects of different substances on the early stages of papillary stone formation.
    Grases F; Garcia-Ferragut L; Costa-Bauzá A; March JG
    Nephron; 1996; 73(4):561-8. PubMed ID: 8856252
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of citrate and urine on calcium oxalate crystal aggregation.
    Tiselius HG; Fornander AM; Nilsson MA
    Urol Res; 1993; 21(5):363-6. PubMed ID: 8279094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial simulation of renal stone formation. Influence of some urinary components.
    Grases F; Costa-Bauzá A; March JG; Söhnel O
    Nephron; 1993; 65(1):77-81. PubMed ID: 8413796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Mixtures of Magnesium, Citrate and Phytate as Calcium Oxalate Crystallization Inhibitors in Urine.
    Grases F; Rodriguez A; Costa-Bauza A
    J Urol; 2015 Sep; 194(3):812-9. PubMed ID: 25818031
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulatory effect of the 23-kD calcium oxalate monohydrate binding protein on calcium oxalate stone formation during oxalate stress.
    Asokan D; Kalaiselvi P; Varalakshmi P
    Nephron Physiol; 2004; 97(1):p23-30. PubMed ID: 15153748
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of stone-forming risk by measuring crystal formation in whole urine with gel model.
    Roehrborn CG; Schneider HJ; Rugendorff EW
    Urology; 1986 Jun; 27(6):531-6. PubMed ID: 3716052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of calcium oxalate monohydrate (COM) crystal growth by pyrophosphate, citrate and rat urine.
    Sidhu H; Gupta R; Thind SK; Nath R
    Urol Res; 1986; 14(6):299-303. PubMed ID: 3027939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Studies of experimental calcium oxalate stones. 2. The preventive effects of phytin and citrate on renal deposition of calcium oxalate induced by ethylene glycol administration].
    Ebisuno S; Morimoto S; Fukatani T; Miyazaki Y; Yasukawa S; Sawada Y; Ohkawa T
    Nihon Hinyokika Gakkai Zasshi; 1985 Jun; 76(6):843-9. PubMed ID: 4068425
    [No Abstract]   [Full Text] [Related]  

  • 13. Uric acid as inducer of calcium oxalate crystal development.
    Grases F; Sanchis P; Isern B; Perelló J; Costa-Bauzá A
    Scand J Urol Nephrol; 2007; 41(1):26-31. PubMed ID: 17366099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of citrate on hydroxyapatite induced calcium oxalate crystallization and on the formation of calcium phosphate crystals.
    Berg C; Tiselius HG
    Urol Res; 1989; 17(3):167-72. PubMed ID: 2546314
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular modifiers reveal a mechanism of pathological crystal growth inhibition.
    Chung J; Granja I; Taylor MG; Mpourmpakis G; Asplin JR; Rimer JD
    Nature; 2016 Aug; 536(7617):446-50. PubMed ID: 27501150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of macromolecules in the formation of kidney stones.
    Rimer JD; Kolbach-Mandel AM; Ward MD; Wesson JA
    Urolithiasis; 2017 Feb; 45(1):57-74. PubMed ID: 27913854
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A method for studying inhibitory activity in whole urine.
    Ryall RL; Hibberd CM; Marshall VR
    Urol Res; 1985; 13(6):285-9. PubMed ID: 3006313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is calcium oxalate nucleation in postprandial urine of males with idiopathic recurrent calcium urolithiasis related to calcium phosphate nucleation and the intensity of stone formation? Studies allowing insight into a possible role of urinary free citrate and protein.
    Schwille PO; Schmiedl A; Manoharan M
    Clin Chem Lab Med; 2004 Mar; 42(3):283-93. PubMed ID: 15080561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.